Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Info for anyone who’s interested:
Another email from Awesome Penny Stocks (I make money more often than not with these guys)
OXYS-OXYSURE has a potential short squeeze breakout coming up Monday and Thursday!
We believe Monday will help set the course for the remaining week. OXYS is a stock that we initially brought to our subscribers attention under .01. We believe next week will complete the final leg of the uptrend that we were predicting two months ago. According to our calculations Market Makers will have to cover millions of shares they shorted next week. We based our opinion by taking looking at the short squeeze data found on https://www.otcshortreport.com/company/OXYS If you look at the days May 17th and May 21st both those days there were over 1.6 million shares shorted. The pattern we have been noticing is Short sellers are covering their short positions after 30 days. When they cover it can create a buying frenzy causing for the price to skyrocket. That is what we are hoping for next week!
Info for anyone who’s interested:
Another email from Awesome Penny Stocks (I make money more often than not with these guys)
OXYS-OXYSURE has a potential short squeeze breakout coming up Monday and Thursday!
We believe Monday will help set the course for the remaining week. OXYS is a stock that we initially brought to our subscribers attention under .01. We believe next week will complete the final leg of the uptrend that we were predicting two months ago. According to our calculations Market Makers will have to cover millions of shares they shorted next week. We based our opinion by taking looking at the short squeeze data found on https://www.otcshortreport.com/company/OXYS If you look at the days May 17th and May 21st both those days there were over 1.6 million shares shorted. The pattern we have been noticing is Short sellers are covering their short positions after 30 days. When they cover it can create a buying frenzy causing for the price to skyrocket. That is what we are hoping for next week!
I got that too
I copy and pasted the following from an email I received this morning from Awesome Penny Stocks:
OXYS- OXYSURE
Estimated short squeeze breakout on or before June 18th
500 million Authorized shares, 36 million outstanding shares,
Company website oxysure.com
Oxysure Therapeutics considers themselves the leader in emergency short-term duration medical oxygen and respiratory solutions.
Have FDA approval for Oxysure model 615 with a long-term goal of being able to sell 500 million units worldwide.
Our price target of .15-.30 still stands over the next 3 weeks we believe there is one major short squeeze remaining.
Agreed. It will be an interesting week after such low volume.
Rebounded fairly well today on low volume ...good sign moving forward.
One can always jump back in
You pulled out just before take off!
You’ll never go broke taking profit!
No issues here from me. You need to be comfortable with your trades. Watch the patterns on the chart and jump back in on the next leg.
I was one of them and have no regrets - I’ve been burned to many times. I made a nice profit and will buy back in for a second round, if it runs.
Good luck to all.
Well it's working. People panick selling this morning. I have faith in this stock that it will continue the overall upward trend. Stay patient.
ETRF is trying real hard today. They must be in a world of hurt.
They can have mine also. I’ll happily give them up...for a price!
Ive offered them my shares. Even have sell orders out so they can grab them. They just need to pay my PPS, not their’s ;)
Lol, it’s called “patient” not stubborn. They know they need to cover and will try whatever they can to avoid losing $$$. But the smart traders like the people on this board know there’s much higher prices to sell at
The MM’s May be stubborn, but I am stubborner! Lol. Tic toc!
Just a waiting game. MMs trying to walk the ask down to encourage covering them on the bid. No selling on bid = $.15-$.25
Yep, any time now between today and Friday it should pop
It’s a beautiful thing to see the volume so stagnant. . . I believe this is all setting up for a nice pop tomorrow.
Nobody is selling. They know this has potential of $.25 once MMs cover
I’ll staying for now...I’m still up nicely and have room to play with, which is a comfortable position to be in.
I think this is ready to make a huge move up and I don’t want to miss it :)
Appreciate the contact.
Did you decide to stay or go? Looks like you may be rewarded this week if you stayed...imo.
I wish I would have found this diamond at a penny!
It showed up on one of my scans about six weeks ago (back when it was trading at about a penny). I made a small buy and a couple days later started hearing some buzz in some chat rooms. Seeing the small SS and the growing buzz, I saw the short squeeze potential and made a larger buy. Buzz has gotten much bigger than I expected (I thought we would be peaking around 0.05 initially).
Who knows what the upward potential is now. As long as the MMs keep shorting selling to each other to cover, this will keep going up every 2-2.5 weeks.
How did you find OXYS?
I am expecting a big push up this week. Two weeks ago we went from 0.06 to 0.11, I expect this leg to have a similar kick. I save ASCM selling into ASCM quite a bit today. This is potentially setting up for an additional squeeze once we stabilize at the next level. I am adjusting my selling strategy accordingly....
CSTI is fine. One of my sell orders is going through CSTI (I believe the 0.30 pps one) and it pops up on level 2 from time to time.
ASCM and ETRF are the big losers. ASCM appears to be near panicz. Haven’t seen much CANT on the ask and the little I have seen has looked to be retail selling. NITE also appears to only be retain buys/sells.
But you never know when five digit orders come through which MM is orchestrating it.
Looked like MMs covered into CANT, about 200-300k shares today. I haven’t seen CANT cover at all yet, so any day now, CANT might be screwed for 1mil+ shares. Haven’t seen CSTI cover in last 30 days either, so should see a lot of upward movement still this week.
Don’t let em off the hook by selling into the bid. Make em pay!
It is more just paying attention. All the MMs are buying and selling based on their algorithms. They are there creating the market (just as they are supposed to - i am not a believer that MMs are out to screw us investors).
When the MMs start to run short inventory, the short position mitigation algorithm kicks in. This makes their moves somewhat predictable. Also, depending on how short they are, more drastically algorithms kick in.
Under a normal market, these algorithms will stabilize the situation. But when nobody is selling, the algorithms fail. Last ditch algorithm is to buy shares at whatever price we want so the short position is covered.
This is why the daily charts have maintained a pretty consistent pattern over the past month.
Kalister, you sound very educated on MM’s. Thank you for the information.
With the way this is playing out. I think we may have another leg in this....MMs being forced to short shares to themselves to buy time...
Spread just tightened up!
And look at that level 2. Nobody is selling....
Great volume today. Something’s got to give.
This is the setup where it can run to .25+
Looks like ASCM and ETRF May be starting to sweat a bit. Expect the typical reindeer games...
I agree Vader. At that point we will rock and roll.
Should see higher highs and higher lows until MMs have to cover their shorts
$.15+ easy this week if retail selling holds off
MM are manipulating so they can cover at a lower pps. That only works if folks sell. They weren’t expecting the retail bids to op up like they did. It negated their plans. We are one day closer to MM panic.
BTW, everyone needs to trade at a risk level they are comfortable with. I’ll never pressure one to buy, sell, or hold. We all have different pain tolerances for pps fluctuations. Nobody on these boards care about your money except you. Take that responsibility seriously.
Have a great weekend!
I’ll continue to monitor and I’m currently comfortable holding, but this morning peaked my attention. I’m good with the current level, but hope for a pop soon. I agree that it will pop and when it does, it’s going to be good and fast.
Appreciate the response.
You need to trade the way you are comfortable with. No issues from me.
I do feel this will pop, so I am holding on for higher pps.
I’ll probably bail soon, I’m not going below my initial price, then reevaluate my Buy-in again.
They are walking the pps down. ETRF, ASCM, and CDEL are all getting nervous. This could make for a fun afternoon....
Looking forward to tomorrow. Should be a great day!
This is winding up nicely for the next leg. ASCM is starting to feel the pressure. Low volume means nobody is fooled. This will rip soon.
Followers
|
34
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1154
|
Created
|
01/16/13
|
Type
|
Free
|
Moderators |
OxySure Systems, Inc. (OXYS) is a medical technology company that focuses on the design, manufacture, and distribution of specialty respiratory and medical solutions. The company pioneered a safe and easy--to-use solution to produce medically pure (USP) oxygen from inert powders. The company owns numerous issued patents and patents pending on this technology which is designed to make the provision of emergency oxygen safer, more accessible, and easier to use than traditional oxygen provision systems.
OXYS' products improve access to emergency oxygen that affects the survival, recovery, and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory, or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other "Immediately Dangerous to Life or Health" (IDLH) environments.
OXYS manufactures its products at a manufacturing facility in Frisco, Texas. The product has also been deployed in several other countries, including Brazil, Israel, Turkey and South Africa.
Investment Highlights
Media Coverage
Products
OXYS has developed a unique platform technology whereby medically pure oxygen is created instantly from two dry inert powders, allowing oxygen to be delivered on demand. Using this technology, the company has developed the OxySure Model 615.
With Model 615, there are no compressed tanks, no dials, no valves, no regulatory maintenance, no hydrostatic testing, no batteries, and no required training. The technology is both safe and easy-to-use for the layperson and is available over the counter. Like an AED or fire extinguisher, Model 615 can be placed just about anywhere a medical emergency might occur to help improve medical outcomes and save lives by bridging the gap between a medical emergency and the arrival of first responders on the scene.
(1. Plug in the Mask 2. Turn the Knob 3. Place the mask over the nose and mouth)
There is no storage of oxygen; the oxygen is created on demand. As a result, the Model 615 eliminates the dangers traditionally associated with compressed tanks.
Other unique characteristics:
Product Selling Points
OXYS’ Model 615 is a pioneering technology that is defining a new market with no direct competition, providing a solution to problems with existing emergency oxygen, such as:
Compressed Cylinders
Chemical Generators
Enormous Markets
OXYS is targeting enormous end markets that are at least as large as the install base for AEDs, which exceeds 2 million units, and potentially as large as the fire extinguisher base, which exceeds 100 million units in the U.S. (500+ million units globally).
Already Approved
Model 615 has already been cleared by the U.S. Food & Drug Administration for over-the-counter (OTC) sale without the need for a prescription, and is already in the commercialization phase.
Recurring Revenue Model
Model 615 consists of a reusable housing and a replaceable cartridge, which must be replaced after each use or upon expiry of a 2-year shelf life. Over time, this results in recurring revenues and greater earnings predictability.
Future products
OXYS’ “oxygen from powder” technology also allows the company to develop much needed solutions for other vertical markets such as aviation, mining, and sports & recreation markets.
Market Opportunity
OXYS has been primarily focused on establishing partnerships with distributors, as well as reaching out to large OEM customers that may be able to expand its presence in the marketplace.
The company’s aim is to bridge the gap between an emergency situation and the arrival of first responders. According to USA Today, this gap is currently an average 6-15 minutes. AEDs address this gap, but oxygen has always been missing. OXYS’ technology is applicable to an alarmingly high population of at-risk individuals:
OXYS’ Model 615 is currently installed internationally in a variety of locations, including:
The company believes that its technology has potential for market placement in:
School Mandates
OXYS believes that there is dire need for mandating emergency oxygen in schools, requiring that an FDA-cleared, non-compressed oxygen source suitable for use by lay rescuers be made widely available.
AEDs are currently mandated in schools in 24 states:
Oxygen administration is often the first requirement in a medical emergency. The standard of care (SOC) today for first responders is to administer oxygen immediately upon arrival. Having an AED nearby would enable nurses, teachers, school administrators, and athletic trainers to “bridge the gap” by applying oxygen sooner, improving medical outcomes and saving lives, as well as minimizing absenteeism and saving millions of dollars for school districts.
Growth Strategy & Sales Model
OXYS’ technologies target a number of enormous end markets. With plans to initially target the 102,265 educational campuses in the U.S., the 350,735 manufacturing facilities, the 350,000 churches, and the 950,000 restaurants, the company could see a relatively large installed base over the near-term.
In the long run, the company aims to place its technology in any public or private place where people are at risk. From recreational vehicles to restaurants to federal buildings, the potential end markets for the Model 615 are at least as numerous as AEDs (2+ million units) and potentially as large as fire extinguishers (100+ million) in the U.S. The markets outside of the U.S. increase the global market size for OXYS to at least 500+ million units.
The company aims to capitalize on these markets primarily through partnerships with distributors and OEM customers. To execute this goal, the company has created a blueprint for growth:
Increase Sales to Existing and New Customers
Introduce New Products / Services and Channels
Pursue Market Catalysts
Marketing support:
Outlook
In the next 3-5 years OXYS aims to add more than 100 new distributors and grow its direct sales force and strategic accounts teams to more than 500 individuals. OXYS also intends to pursue legislation and mandates that would require life-saving devices such as Model 615 in public facilities. In addition, OXYS will:
Management Team
Julian T. Ross, MBA, Chairman & CEO
Julian T. Ross is the OxySure founder, technology developer (holds 9 patents), and CEO. He has more than 25 years of experience in technology, manufacturing, and finance. He has managed development of production capabilities, partnerships and alliances, managed the development of sales, distribution and licensing partnerships, raised in excess of $14 million in debt and equity to fund operations, and took OXYS public in 2011 through an S-1 registration with the Securities and Exchange Commission. Ross’ other experience includes: roll-up, technology companies; $315 million high yield debt offering (Merrill Lynch/Salomon Brothers in lead, plus Deutsche Morgan Grenfell, Nomura Securities).
Jeremy “Jerry” Jones, Director
Jeremy Jones has more than 35 years in healthcare leadership. He was former chairman/CEO of Apria Healthcare (sold to Blackstone for $1.7 billion) and chairman of On Assignment (ASGN), a $1.3 billion healthcare services leader. His current and former boards include: CombiMatrix Corp. (CBMX); Byram Healthcare Centers Inc. (chairman); (3) Lifecare Solutions, Inc. (chairman) (4) US Labs, Inc. (acquired by Lab Corp in 2005; (5) Cardium Healthcare (acquired by CenCorp Health in 2006). He was formerly chairman of the Health Industry Distributors Association (HIDA) and is founding chairman of the Home Oxygen Services Coalition. He has also received the Dr. Jonas Salk Memorial Mentor in Medicine Award from the March of Dimes.
Vicki Jones, MBA, Director
Don Reed, BA, BS – Director
Dr. Vincent Mosesso, Jr., MD, FACEP – Advisory Board
Dr. James R. Winn, MD – Advisory Board
Dr. Thomas D. Franklin, Jr. – Advisory Board
Dr. Jonathan E. Burke, DMD – Advisory Board
Dr. R. Dean White, D.D.S., M.S. – Advisory Board
OxySure Systems, Inc. |
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |